Navigation Links
FHI Selected as Preferred Provider to a Consortium of Product Development Partnerships
Date:3/30/2011

RESEARCH TRIANGLE PARK, N.C., March 30, 2011 /PRNewswire-USNewswire/ -- FHI has been selected as one of six preferred providers offering their clinical research expertise to a consortium of 14 global health Product Development Partnerships (PDPs). The consortium of PDPs is working to develop and deliver affordable treatments and vaccines that will help improve the lives of some of the world's most vulnerable people.

FHI's forty years of research experience has focused on a multitude of infectious and neglected diseases, such as HIV, HSV, HPV, other sexually transmitted diseases, malaria, and seasonal and pandemic influenza.  FHI has strong history delivering the highest quality research in resource constrained settings and has been recognized globally for its leadership in the ethical treatment of trial participants.  

"This consortium has the potential to find cures for the most widespread diseases, like tuberculosis, malaria, influenza, dengue fever, HIV and Chagas disease," said Albert J. Siemens, FHI Chairman and Chief Executive Officer.  "FHI is honored to be selected as a preferred provider, offering our expertise and experience to the critical work being undertaken by the PDPs."

The consortium members are funded, in part, by the Bill & Melinda Gates Foundation. This preferred provider agreement offers consortium members an opportunity to work with pre-qualified organizations, including FHI, thereby consolidating resources, and achieving heightened efficiencies while maintaining the highest standards.  The synergies and efficiencies of partnering with the preferred providers are expected to be significant.  

FHI partners with government, non-governmental, and private sector entities on major pharmaceutical and biotechnology clinical trials worldwide.

About FHI

FHI is a global health and development organization whose science-based programs bring lasting change to the world's most vulnerable people.  FHI's approach is rigorous and evidence-driven.  Among FHI's worldwide staff of 2,500 are leading physicians, scientists, and technical experts in health, development, and management.  FHI's work is global in scale yet country-focused, with international offices staffed by local professionals.  Since 1971, FHI has worked with 1,400 partners in 125 countries, forging strong relationships with governments, diverse organizations, the private sector and communities.  By applying science to healthcare programs and clinical research, FHI is helping countries make measurable progress against disease, poverty, and inequity – improving lives for millions.

Contact Info:
Matthew Matassa
202-341-6519
mmatassa@fhi.org


'/>"/>
SOURCE Family Health International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Selected for Inclusion in RB Milestone Portfolio
2. Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
3. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
4. BioSurplus Selected to Liquidate Discovery Laboratory Equipment
5. Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance
6. Valence Health Selected by Cleveland Clinic to Support Clinical Integration Program
7. Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study
8. Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting
9. GENFIT Selected by Windhover for the 2011 Top Biopharma Projects To Watch
10. PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades
11. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , February 8, 2016 ... report published by Allied Market Research titled, "World ... and Forecasts, 2014-2020", estimates the world synthetic biology ... synthesis and sequencing technology segment would continue to ... software tools segment, collectively, held around half of ...
(Date:2/5/2016)... N.C. , Feb. 5, 2016  Despite the ... been slower than other industries to embrace Big Data ... with utilization. On the medical side, organizations have begun ... everything from clinical trials to adherence. ... from benchmarking firm Best Practices, LLC, Big Data has ...
(Date:2/5/2016)... 5, 2016  Syneron Medical Ltd. (NASDAQ: ... announced today that William Griffing , Chief ... scheduled to participate in the Leerink Partners 5 ... 11, 2016 in New York City ... to meet with the Mr. Griffing and will ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
(Date:2/8/2016)... ... 08, 2016 , ... GrassrootsHealth published data from its D*action ... diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels than a ... health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of ...
(Date:2/8/2016)... ... 08, 2016 , ... The schedule is now online for the ... Conference, which is being held May 25-29 at the Loews Chicago O’Hare Hotel, continues ... and causes of chronic illness in children. , Very recent articles have cited 1 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):